Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Panminerva Med ; 34(2): 93-5, 1992.
Article in English | MEDLINE | ID: mdl-1408335

ABSTRACT

The authors deal with a case of Histoplasmosis in a 50 yr old Italian man without any history of risk exposure to HIV infection and suffering from mycosis fungoides. Although this infection is rare in Europe and particularly in Italy, this case suggests the possibility that soils capable of supporting the saprophytic fungus growth are present even out of the endemic areas.


Subject(s)
Histoplasmosis/complications , Lung Diseases, Fungal/complications , HIV Seropositivity/complications , Humans , Italy , Male , Middle Aged , Mycosis Fungoides/complications
2.
Monaldi Arch Chest Dis ; 50(2): 114-5, 1995 Apr.
Article in English | MEDLINE | ID: mdl-7613541

ABSTRACT

Heterozygosity for homocysteinuria is a common, inherited autosomal condition that has recently been considered as an independent cardiovascular risk factor. In vitro and in vivo results suggest that this condition, like the homozygous form, is also a risk factor for deep-venous thrombosis and pulmonary thromboembolism. We report a case of recurrent pulmonary thromboembolism in a young woman with familial hyperhomocysteinaemia. The relative frequency of this condition, as well as its simple and harmless cure, make testing for heterozygosity for homocysteinuria useful and profitable in the prevention of pulmonary thromboembolism, above all in younger subjects with a significant case history.


Subject(s)
Amino Acid Metabolism, Inborn Errors/genetics , Heterozygote , Homocysteine/urine , Pulmonary Embolism/etiology , Adult , Amino Acid Metabolism, Inborn Errors/diagnosis , Amino Acid Metabolism, Inborn Errors/drug therapy , Female , Heparin/therapeutic use , Homocysteine/genetics , Humans , Pulmonary Embolism/prevention & control , Pyridoxine/therapeutic use , Recurrence , Risk Factors , Thrombolytic Therapy , Thrombophlebitis/etiology , Thrombophlebitis/prevention & control , Urokinase-Type Plasminogen Activator/therapeutic use
3.
Monaldi Arch Chest Dis ; 50(6): 477-81, 1995 Dec.
Article in English | MEDLINE | ID: mdl-8834961

ABSTRACT

In June 1989, an out-patient clinic for asthma was instituted at Crema Hospital, Italy. Up to November 1994, 430 adult asthmatics were recruited, classified and managed according to the recommendations of the international guidelines. The aims of this study are to verify: 1) whether the organization of the clinic could maintain asthma under control and reduce hospital admissions; and 2) whether the traditional educational approach could be implemented by lessons in the school of asthma to improve the control of asthma symptoms and/or admissions. The data reported refer to the first 360 asthmatics attending the clinic between 1989 and 1994: 53, 45 and 2% of them were suffering from extrinsic, intrinsic and occupational asthma, respectively. On recruitment, forced expiratory volume in one second (FEV1) was < 80% of predicted in 170 patients, and arterial oxygen tension (Pa,O2) 8.0 kPa (< 60 mmHg) in 27 patients. After the admission visit, 190 patients (53%) were classified as mild, 97 (27%) as moderate, and 73 (20%) as severe asthmatics. In May 1993, a school of asthma was organized. Forty four patients were recruited, stratified according to the severity of their asthma and randomized into two groups: 22 patients attended the school, and 22 patients did not. Each group consisted of 5, 10 and 7 patients with mild, moderate and severe asthma, respectively. The school comprised four lessons twice a week. One year after the end of the school, we could find no differences between the two groups (school versus controls) with regard to the number of urgent care visits (9 vs 9), scheduled visits (22 vs 21) and hospital admissions (2 vs 2).


Subject(s)
Asthma/prevention & control , Guidelines as Topic , Outpatient Clinics, Hospital , Patient Education as Topic , Adult , Ambulatory Care , Anti-Asthmatic Agents/therapeutic use , Asthma/epidemiology , Asthma/therapy , Female , Follow-Up Studies , Hospitalization/statistics & numerical data , Humans , Italy/epidemiology , Male , Prospective Studies , Time Factors , Treatment Outcome
4.
Clin Ter ; 131(5): 293-7, 1989 Dec 15.
Article in Italian | MEDLINE | ID: mdl-2532583

ABSTRACT

The clinical effectiveness and the pharmacokinetic parameters of a once-a-day sustained release preparation of anhydrous theophylline were studied in a trial carried out on 10 adult patients affected by bronchial asthma or chronic obstructive lung disease. Treatment with this new theophylline preparation allowed us to obtain mean serum concentrations within the therapeutic range (5-20 mcg/ml) which remained quite constant during 24 hours. All patients evidenced improvement of dyspnea and of the signs of bronchospasm. Tolerability was very good.


Subject(s)
Theophylline/administration & dosage , Adult , Aged , Asthma/drug therapy , Bronchitis/drug therapy , Delayed-Action Preparations , Female , Humans , Lung Diseases, Obstructive/drug therapy , Male , Middle Aged , Randomized Controlled Trials as Topic , Time Factors
5.
Recenti Prog Med ; 82(7-8): 402-4, 1991.
Article in Italian | MEDLINE | ID: mdl-1947406

ABSTRACT

Since their introduction in clinical practice beta-blocker drugs are known to be able to induce bronchospasm. However, this adverse effect may develop only in subjects with asthma, chronic bronchitis and/or airways hyper-reactivity. Although this potentially adverse effect of beta-blockers on the airways has long been recognized, its mechanism in inducing bronchospasm remains unclear. The Authors report a case of severe bronchoconstrictive episodes with respiratory failure following the administration of a timolol ophthalmic solution in a 51 yr old woman. Pharmacokinetics, preventive and therapeutic aspects of timolol eyedrop-induced bronchospasm are discussed.


Subject(s)
Bronchial Spasm/chemically induced , Ophthalmic Solutions/adverse effects , Timolol/adverse effects , Female , Humans , Middle Aged , Respiratory Insufficiency/chemically induced
7.
Respiration ; 61(6): 310-6, 1994.
Article in English | MEDLINE | ID: mdl-7824810

ABSTRACT

Bi-level pressure support ventilation via a nasal mask (NIPSV) was provided to 28 consecutive unselected patients with acute respiratory failure due to exacerbation of chronic obstructive pulmonary failure (COPD). If NIPSV improved gas exchange within 2 h, it was continued. Otherwise, patients would be promptly intubated. The patients median age was 68 years (minimum 56, maximum 82). The arterial blood gas drawn before initiating NIPSV showed (FiO2 21%) a mean PaO2 of 41.3 +/- 6 mm Hg, a mean PaCO2 of 66 +/- 15 mm Hg and a mean pH of 7.31. Upon admission the mean respiratory rate was 36 breaths/min and the median Apache II score was 20.5 (minimum 13, maximum 32). Despite oxygen administration all patients failed to improve their PaO2 and/or showed a consistent and dangerous hypercapnic response. NIPSV was performed with a median inspiratory positive airway pressure of 14 cm H2O (minimum 10, maximum 20) and a median expiratory positive airway pressure of 4 cm H2O (minimum 3, maximum 6). Eighteen patients (64%) were successfully ventilated with NIPSV, while in 10 (36%) NIPSV failed. A high Apache II score, but not admission blood gas exchange or respiratory rate, seems to be correlated with the failure to ventilate with NIPSV. The results of our preliminary experience suggest the use of NIPSV as an initial approach to acute respiratory failure due to exacerbation of COPD, particularly in patients with an Apache II score of less than 29.


Subject(s)
Lung Diseases, Obstructive/complications , Positive-Pressure Respiration , Respiratory Insufficiency/therapy , Acute Disease , Aged , Aged, 80 and over , Female , Humans , Lung Diseases, Obstructive/physiopathology , Male , Masks , Middle Aged , Oxygen/blood , Positive-Pressure Respiration/instrumentation , Pulmonary Gas Exchange , Respiration , Respiratory Insufficiency/etiology , Respiratory Insufficiency/physiopathology
8.
Eur Respir J ; 9(3): 422-30, 1996 Mar.
Article in English | MEDLINE | ID: mdl-8729999

ABSTRACT

Noninvasive positive pressure ventilation (NPPV) has been proposed in COPD patients with acute on chronic respiratory failure (ACRF) in order to avoid endotracheal intubation and to improve immediate outcome, but long-term outcome of this therapeutic approach is still undefined. We evaluated short- and long-term (1 year) outcome of early administration of NPPV in 24 patients with ACRF due to exacerbated COPD (Group A) in comparison with 24 matched historical-control patients treated conventionally (Group B). Patients of Group A were initially treated with NPPV via nasal mask in the presence of pH < or = 7.32, and/or Pa,O2 < 7.98 kPa, and/or Pa,CO2 > 7.18 kPa, plus signs of respiratory distress. In-hospital survival rate was not significantly different in Group A vs Group B, but the patients treated with NPPV showed an earlier improvement in blood gases and a better pH and respiratory rate at discharge. Only 2 patients of Group A needed endotracheal intubation as compared with 9 of Group B. Hospital stay was significantly reduced in survivors of Group A vs Group B. Further severe relapses of ACRF in Group A were treated using NPPV. The number and length of further hospitalizations for pulmonary exacerbations were significantly higher in Group B compared with Group A. The survival rate at 12 months was significantly lower in Group B than in Group A (50% vs 71%). In conclusion, NPPV administration in patients with ACRF due to exacerbated COPD improves not only immediate but also long-term outcome.


Subject(s)
Intermittent Positive-Pressure Ventilation , Lung Diseases, Obstructive/therapy , Respiratory Insufficiency/therapy , Acute Disease , Aged , Aged, 80 and over , Analysis of Variance , Blood Gas Analysis , Case-Control Studies , Evaluation Studies as Topic , Female , Humans , Intermittent Positive-Pressure Ventilation/methods , Length of Stay , Lung Diseases, Obstructive/complications , Lung Diseases, Obstructive/physiopathology , Male , Middle Aged , Prospective Studies , Respiratory Insufficiency/complications , Respiratory Insufficiency/physiopathology , Survival Rate , Time Factors , Treatment Outcome
9.
Eur J Epidemiol ; 10(4): 435-9, 1994 Aug.
Article in English | MEDLINE | ID: mdl-7843347

ABSTRACT

Reports of a few apparently autochthonous cases of human histoplasmosis and results of epidemiological research suggested the autochthonous presence of the disease in Italy. Identifying two new histologically documented cases of Italian patients, who had never been abroad, and, the positive results of a histoplasmin reactivity survey carried out in the Province of Cremona, Italy confirmed this possibility.


Subject(s)
Histoplasmosis/pathology , Lung Diseases, Fungal/pathology , Adolescent , Bronchial Diseases/microbiology , Bronchial Diseases/pathology , Fatal Outcome , Female , Histoplasmin , Histoplasmosis/epidemiology , Humans , Italy/epidemiology , Laryngeal Diseases/microbiology , Laryngeal Diseases/pathology , Male , Middle Aged , Pharyngeal Diseases/microbiology , Pharyngeal Diseases/pathology , Population Surveillance , Skin Tests , Tracheal Diseases/microbiology , Tracheal Diseases/pathology , Travel
SELECTION OF CITATIONS
SEARCH DETAIL